Gilead Sciences



Ebitda Changement Date
AbbVie USD 6.92B 258M 2024-12
Agios Pharmaceuticals USD -105351000 18.32M 2025-03
ALKERMES USD 21.21M 142.21M 2025-03
Alnylam Pharmaceuticals USD 32.48M 123.47M 2025-03
Amgen USD 3.75B 42M 2025-03
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 245.96M 51.11M 2025-03
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Eli Lilly USD 4.16B 2B 2025-03
Gilead Sciences USD 3.21B 651M 2024-12
GlaxoSmithKline GBP 3.14B 1.06B 2025-03
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Incyte USD 222.66M 97.54M 2025-03
J&J USD 7.88B 1.76B 2025-03
Merck USD 7.74B 625M 2025-03
Moderna USD -924000000 69M 2025-03
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 6.17B 339M 2025-06
Pfizer USD 6.21B 1.5B 2025-03
PTC Therapeutics USD 1.07M 47.25M 2024-12
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Sanofi EUR 2.86B 2.3B 2025-03
Sarepta Therapeutics USD -290408000 472.62M 2025-03
United Therapeutics USD 402.6M 19.2M 2025-03
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12


Gilead Sciences - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.